Stage IIIB Breast Cancer Completed Phase 1 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01158274RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsTreatment